Scarica l'app Stockscreener
1.80
1.68%
-0.03
Hillevax Inc Borsa (HLVX) Ultime notizie
Insider Selling: Kohli Aditya, HilleVax Inc [HLVX] Director divested 6,000 shares - Knox Daily
Investigation announced for Investors who lost money with shares of HilleVax, Inc. (NASDAQ: HLVX) - openPR
Should investors be concerned about HilleVax Inc (HLVX)? - US Post News
Ratio Examination: HilleVax Inc (HLVX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Analysts Set HilleVax, Inc. (NASDAQ:HLVX) Price Target at $9.20 - MarketBeat
HilleVax Inc (HLVX)’s results reveal risk - US Post News
HilleVax, Inc. (NASDAQ:HLVX) Given Average Rating of “Hold” by Analysts - Defense World
Recent Insider Activity Could Benefit HilleVax Inc (HLVX) - Knox Daily
How to interpret HilleVax Inc (HLVX)’s stock chart patterns - US Post News
HLVX Shares Experience Surge in Value - Knox Daily
What is HilleVax Inc (HLVX) Stock Return on Shareholders’ Capital? - SETE News
HilleVax, Inc. (NASDAQ:HLVX) Short Interest Up 32.8% in July - Defense World
Financial Analysis: HilleVax Inc (HLVX)’s Ratios Unveil Key Insights - The Dwinnex
HilleVax, Inc. (NASDAQ:HLVX) Short Interest Update - MarketBeat
HilleVax Inc [HLVX] Records 50-Day SMA of $7.1060 - Knox Daily
Are Smart Investors Making the Right Decision? HilleVax Inc (HLVX) - SETE News
Q3 2024 Earnings Forecast for HilleVax, Inc. (NASDAQ:HLVX) Issued By HC Wainwright - Defense World
Q3 2024 Earnings Forecast for HilleVax, Inc. (NASDAQ:HLVX) Issued By HC Wainwright - MarketBeat
HilleVax Inc’s results are impressive - US Post News
HC Wainwright Reiterates Neutral Rating for HilleVax (NASDAQ:HLVX) - MarketBeat
Tidal Investments LLC Makes New $207,000 Investment in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
HC Wainwright Reiterates Neutral Rating for HilleVax (NASDAQ:HLVX) - Defense World
HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Vanguard Group Inc. - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc.HLVX - PR Newswire
HLVX Stock Earnings: HilleVax Misses EPS for Q2 2024 - InvestorPlace
Vaccine Developer HilleVax Stock Nosedives On MondayHere's Why - MSN
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress - ForexTV.com
This trade activity should not be overlooked: HilleVax Inc (HLVX) - SETE News
HilleVax Inc (HLVX) receives a Hold rating from Stifel - Knox Daily
HLVX underperforms with a -5.88 decrease in share price - US Post News
Market Watch: HilleVax Inc (HLVX)’s Noteworthy Drop, Closing at 1.70 - The Dwinnex
Analysts Set HilleVax, Inc. (NASDAQ:HLVX) Target Price at $9.20 - MarketBeat
HilleVax, Inc. (NASDAQ:HLVX) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
HilleVax announces major workforce reduction, cuts 40% By Investing.com - Investing.com Australia
HilleVax slashes workforce by 40% after norovirus vaccine trial failure - Pharmaceutical Technology
UniQure, Arbutus and HilleVax all lay off staff as biotechs streamline operations and cut costs - Fierce Biotech
HilleVax Lays Off 40% Of Workforce - Contract Pharma
You might want to take a look at HilleVax Inc (HLVX) now - SETE News
HilleVax hobbling on but cuts 40% of workers - The Pharma Letter
HilleVax announces major workforce reduction, cuts 40% - Investing.com
HilleVax announces major workforce reduction, cuts 40% - Investing.com India
HilleVax to Cut About 40% of Workforce - MarketWatch
HilleVax Announces Reduction in Force - StockTitan
HilleVax Inc (HLVX) gets rating Downgrade from Stifel - Knox Daily
Analytical Overview: HilleVax Inc (HLVX)’s Ratios Tell a Financial Story - The Dwinnex
Stakeholders Of HilleVax Inc Are Encouraged By The Schall Law Fi - WICZ
Norovirus Vaccine Market Development Status 2034 |Hillevax, Vaxart, Moderna, UMN Pharma, Daiichi Sankyo, Kanghua Biology – Moose Gazette - Moose Gazette
Stakeholders Of HilleVax Inc Are Encouraged By The Schall Law Firm To Join The Alleged Securities Fraud Investigation - AccessWire
Kamala Harris VP Choice Decision Is Coming Soon. Shapiro, Walz Emerge as Biggest Contenders. - Barron's
HLVX overperforms with a 1.07 increase in share price - US Post News
After Plunging -86.93% in 4 Weeks, Here's Why the Trend Might Reverse for HilleVax (HLVX) - Yahoo Canada Finance
Analyst Stifel Price Target And Rating For HilleVax Inc (HLVX) - Stocks Register
HilleVax Inc (HLVX) expanding its growth trajectory ahead - SETE News
HLVX (HilleVax Inc) may reap gains as insiders became active recently - Knox Daily
Market Momentum Report: HilleVax Inc (HLVX)’s Positive Close at 1.94 - The Dwinnex
HilleVax clears $26.2M debt, ends loan agreement with Hercules Capital - Investing.com Canada
HilleVax clears $26.2M debt, ends loan agreement with Hercules Capital - Investing.com
HilleVax, Inc. Clears $26.2M Debt and Ends Loan Agreement - TipRanks
How should investors view HilleVax Inc (HLVX)? - US Post News
HKVX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Shareholders to Contact the Firm Today! - AccessWire
HKVX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm Today! - AccessWire
1.19%
1.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):